Vascular access thrombosis is not related to presence of antiphospholipid antibodies in patients on chronic hemodialysis [5]

Nephron

Volumn 92, Issue 4, 2002, Pages 957-958

  Palomo, Iván ^c   Pereira, Jaime ^a   Alarcón, Marcelo ^d   Vasquez, Marcela ^d   Pierangeli, Silvia ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

^c UNIVERSIDAD DE TALCA   (Chile)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; CUPROPHANE; HEPARIN; IMMUNOGLOBULIN G; KAOLIN; LUPUS ANTICOAGULANT; PHOSPHATIDYLSERINE ANTIBODY; PHOSPHOLIPID ANTIBODY; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTERIOVENOUS FISTULA; AUTOIMMUNE DISEASE; BLOOD CLOTTING TIME; CHRONIC GLOMERULONEPHRITIS; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MEMBRANE FILTER; NEPHROSCLEROSIS; PATHOGENESIS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SAMPLE; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; VASCULAR ACCESS;

ADULT; AGED; ANTIBODIES, ANTIPHOSPHOLIPID; CATHETERS, INDWELLING; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; THROMBOSIS;

EID: 12244250823     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065580     Document Type: Letter

References (11)

1. Kinnaert P, Vereerstraeten P, Toussaint C, Van Geertruyden J: Nine years' experience with internal arteriovenous fistulas for haemodialysis: A study of some factors influencing the results. Br J Surg 1977;64:242-246.
2. Schwab SJ, Raymond JR, Saeed M, Newman GE, Dennis PA, Bollinger RR: Prevention of hemodialysis fistula thrombosis: Early detection of venous stenoses. Kidney Int 1989;36:707-711.
3. Mitsiev I, Reinhold S, Ziemer S, Neumayer HH, Hocher B: Combination of APC resistance and acquired protein S deficiency in a haemodialysis patient with recurrent A-V shunt thrombosis. Nephrol Dial Transplant 1999;14:2474-2477.
4. Haviv YS: Association of anticardiolipin antibodies with vascular access occlusion in hemodialysis patients: Cause or effect? Nephron 2000;86:447-454.
5. García-Martín F, De Arriba G, Carrascosa T, Moldenhauer F, Martin-Escobar E, Val J, Saiz F: Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease. Nephrol Dial Transplant 1991;6:543-547.
6. Sitter T, Spannagl M, Schiff H: Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus. Ann Hematol 1992;65:79-82.
7. Ferlazzo B, Barrile A, Bonanno D, Quattrocchi P, Santoro D, Savica D, Bellinghieri G: Anti-cardiolipin antibodies in haemodialysis patients and in renal transplant recipients: Prevalence and significance. Recenti progressi in medicina 1998;89:434-437.
8. Fabrizi F, Sangiorgio R, Pontoriero G, Corti M, Tentori F, Troina E, Locatelli F: Antiphospholipid (aPL) antibodies in end-stage renal disease. J Nephrol 1999;12:89-94.
9. Valeri A, Joseph T, Radhakrishnan J: A large prospective survey of anticardiolipin antibodies in chronic hemodialysis patients. Clin Nephrol 1999;51:116-121.
10. Ducloux D, Florea A, Rebibou JM, Jamali M, Chalopin JM: Anti-beta 2-glycoprotein I and anti-prothrombin antibodies in haemodialysis patients. Nephrol Dial Transplant 1997;12: 2466-2467.
11. Garcia-Martin F, De Arriba G, Carrascosa T, Moldenhauer F, Martin-Escobar E, Val J, Saiz F: Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease. Nephrol Dial Transplant 1991;6:543-547.